Lipigon Pharmaceuticals AB (publ) (STO:LPGO)
Sweden flag Sweden · Delayed Price · Currency is SEK
0.0030
-0.0002 (-6.25%)
Apr 24, 2026, 5:04 PM CET

STO:LPGO Cash Flow Statement

Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-32.44-25.26-12.13-37.71-41.11
Depreciation & Amortization
0.080.060.020.020.02
Other Operating Activities
0.25-0.230.09-0.02-0.24
Change in Accounts Receivable
1.09-1.2-0.52-0.241.83
Change in Other Net Operating Assets
-4.751.85-1.790.484.21
Operating Cash Flow
-35.77-24.78-14.32-37.47-35.3
Capital Expenditures
-0.11-0.24---0.12
Investing Cash Flow
-0.11-0.24---0.12
Long-Term Debt Issued
4.32----
Long-Term Debt Repaid
-1.5----
Net Debt Issued (Repaid)
2.82----
Issuance of Common Stock
38.234.3843.2722.656
Other Financing Activities
-6.730.2-6.56-3.99-4.91
Financing Cash Flow
34.324.5836.718.6151.09
Foreign Exchange Rate Adjustments
-0.28-0.090.020.24
Miscellaneous Cash Flow Adjustments
---0--
Net Cash Flow
-1.56-20.1522.29-18.8315.92
Free Cash Flow
-35.88-25.02-14.32-37.47-35.42
Free Cash Flow Margin
--243.18%-87.27%--1601.94%
Free Cash Flow Per Share
-0.09-0.18-0.22-2.55-3.93
Levered Free Cash Flow
-22.03-16.34-10.69-23.57-20.42
Unlevered Free Cash Flow
-21.9-16.3-10.69-23.57-20.41
Change in Working Capital
-3.660.65-2.310.246.03
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.